Avanos Medical, Inc. (AVNS)

ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES

Avanos Medical, Inc. (AVNS) was listed on the New York Stock Exchange from October 21, 2014 and stopped trading under the symbol AVNS on July 28, 2026.

Listed On
the New York Stock Exchange
Listed Since
October 21, 2014
Stopped Trading
July 28, 2026
Employees
2,287

About Avanos Medical, Inc.

Avanos Medical Inc is a medical technology company engaged in the development and commercialization of products for pain management and patient care. The company has two reportable segments: Specialty Nutrition Systems and Pain Management and Recovery. The Specialty Nutrition Systems segment provides enteral feeding and neonatal products. The Pain Management and Recovery segment offers surgical pain and recovery products, including pain pumps and radiofrequency ablation solutions for the treatment of chronic pain.

Institutional ownership

In 13F filings for the quarter ended June 30, 2026, 275 institutions reported holding AVNS, with 43.6 million shares worth $1.1 billion in aggregate. The largest reported holder was BlackRock, with 7.5 million shares worth $185.8 million. Of the 5 largest holders listed below, 2 opened new positions in AVNS, 2 added shares and 1 reduced its position during the quarter.

InstitutionSharesValueQuarter change
BlackRock7,468,794$186MAdded 9.13%
Vanguard3,317,437$83MReduced 10.2%
Nexpoint Asset Management2,177,366$54MNew position
State Street2,010,691$50MAdded 1.93%
Tig Advisors1,668,329$42MNew position

Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.

Frequently asked questions

What is AVNS?

Avanos Medical, Inc. (AVNS) was listed on the New York Stock Exchange from October 21, 2014 and stopped trading under the symbol AVNS on July 28, 2026.

Who are the largest institutional holders of AVNS?

In 13F filings for the quarter ended June 30, 2026, the largest reported holders of AVNS were BlackRock, Vanguard and Nexpoint Asset Management.

How many institutions own AVNS?

275 institutions reported a position in AVNS for the quarter ended June 30, 2026, worth $1.1 billion in total.

Did institutions buy or sell AVNS last quarter?

Of the 5 largest reported holders, 2 opened new positions in AVNS, 2 added shares and 1 reduced its position during the quarter. Every reported holder and its change is on the SentiSense ownership page for AVNS.

Every reported institutional holder, plus insider and congressional trades in AVNS, on SentiSense.